Systemic Mastocytoses, Indolent
specificAn indolent mast cell neoplasm characterized by systemic infiltration of skin and internal organs by aggregates of neoplastic mast cells. There is no evidence of mast cell leukemia or clonal hematologic malignancy. Clinically, there is no evidence of palpable hepatomegaly and splenomegaly, malabsorption syndrome, or pathologic fractures.
7
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Systemic Mastocytoses, Indolent(7)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 57.1 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 57.1 |
| 3 | NCI Comprehensive | 57.1 |
| 4 | Duke Cancer InstituteDurham, NC NCI Comprehensive | 57.1 |
| 5 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive | 57.1 |
| 6 | University of Illinois Cancer CenterChicago, IL | 57.1 |
| 7 | Boston University Cancer CenterBoston, MA | 57.1 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →